Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 3,258	$ 3,730
Accounts receivable, net of allowances of $115 in 2021 and $125 in 2020	2,074	2,007
Inventories	2,025	1,916
Prepaid expenses and other current assets	810	758
Total current assets	8,167	8,411
Property, plant and equipment, net	4,582	4,722
Goodwill	3,098	3,217
Other intangible assets, net	1,876	1,671
Operating lease right-of-use assets	581	603
Other non-current assets	1,503	1,395
Total assets	19,807	20,019
Current liabilities:
Short-term debt	301	0
Current maturities of long-term debt and finance lease obligations	209	406
Accounts payable	999	1,043
Accrued expenses and other current liabilities	1,932	1,884
Total current liabilities	3,441	3,333
Long-term debt and finance lease obligations	5,446	5,786
Operating lease liabilities	484	501
Other non-current liabilities	1,621	1,673
Total liabilities	10,992	11,293
Commitments and contingencies
Equity:
Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2021 and 2020	683	683
Common stock in treasury, at cost,182,847,640 shares in 2021 and 178,580,208 shares in 2020	(11,529)	(11,051)
Additional contributed capital	6,131	6,043
Retained earnings	16,967	16,328
Accumulated other comprehensive (loss) income	(3,482)	(3,314)
Total Baxter stockholders’ equity	8,770	8,689
Noncontrolling interests	45	37
Total equity	8,815	8,726
Total liabilities and equity	$ 19,807	$ 20,019